MAP2K5
MAP2K5 (mitogen-activated protein kinase kinase 5, also known as MEK5, MAPKK5, HsT17454 and PRKMK5) is a dual specificity protein kinase of the MAP kinase kinase family. It specifically activates MAPK7/ERK5 and scaffolds a signalling complex linked to cell survival. Browse Assay Genie's current range of MAP2K5 research reagents below, or read on for the biology behind the target.
MAP2K5 is a dual specificity protein kinase that specifically interacts with and activates MAPK7/ERK5. The kinase is itself phosphorylated and activated by MAP3K3/MEKK3 and by atypical protein kinase C isoforms (aPKCs). It also acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAPK5-MAPK7 signalling complex, and activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, in neuronal survival, and in cardiac development and angiogenesis.
In the MAPK/ERK signalling pathway, MAP2K5 acts as a negative regulator of apoptosis in cardiomyocytes. It does so by promoting STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM. The signal cascade it mediates is also involved in growth factor-stimulated cell proliferation and muscle cell differentiation. The MAP2K5 protein belongs to the protein kinase superfamily, in the STE Ser/Thr protein kinase family and the MAP kinase kinase subfamily.
The human MAP2K5 gene is classed by HGNC in the mitogen-activated protein kinase kinases group, and its mouse and rat orthologs are both named Map2k5. Three alternatively spliced transcript variants encoding distinct isoforms have been described. The gene has also appeared in the literature under the symbols MEK5, MAPKK5, HsT17454 and PRKMK5, so all of these names are worth searching when you review the literature.
MAP2K5 specifically activates MAPK7/ERK5, making it the defining upstream kinase for studying this branch of MAP kinase signalling.
The MAP2K5 pathway appears to protect cells from stress-induced apoptosis and supports neuronal survival.
MAP2K5 signalling is linked to cardiac development and angiogenesis, and suppresses apoptosis in cardiomyocytes via CREM ICER-type isoform degradation.
The cascade mediated by MAP2K5 is involved in growth factor-stimulated cell proliferation and in muscle cell differentiation.
MAP2K5 is a dual specificity kinase that specifically activates MAPK7/ERK5. It also scaffolds a MAP3K2/MAP3K3-MAPK5-MAPK7 complex. This signalling helps protect cells from stress-induced apoptosis and contributes to neuronal survival, cardiac development, angiogenesis, proliferation and muscle cell differentiation.
MAP2K5 is also known as MEK5, MAPKK5, HsT17454 and PRKMK5, and its HGNC full name is mitogen-activated protein kinase kinase 5. NCBI Gene reports three alternatively spliced transcript variants of the gene, which encode distinct isoforms.
Mouse and rat both have an ortholog named Map2k5. In humans, MAP2K5 is phosphorylated and activated by MAP3K3/MEKK3 and by atypical protein kinase C isoforms. Check the datasheet of any product for its validated reactivity.
Other MAP kinase kinases and MAP3K family members that act in or alongside MAP2K5 signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13163; product specifications from Assay Genie datasheets.